SciSparc Ltd.(SPRC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRC SciSparc Ltd.

交易中 08-19 12:31:51 EDT

6.80

+0.29

+4.38%

最高6.80	最低6.40	成交量5,573
今开6.51	昨收6.51	日振幅6.14%
总市值389.52万	流通市值329.63万	总股本57.32万
成交额3.70万	换手率1.15%	流通股本48.51万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRC","market":"US","secType":"STK","nameCN":"SciSparc Ltd.","latestPrice":6.795,"timestamp":1787157056680,"preClose":6.51,"halted":0,"volume":5573,"delay":0,"changeRate":0.043778801843318,"floatShares":485100,"shares":573243,"eps":-98.07143,"marketStatus":"交易中","change":0.285,"latestTime":"08-19 12:31:51 EDT","open":6.51,"high":6.8,"low":6.4006,"amount":36979.641500000005,"amplitude":0.061352,"askPrice":7.09,"askSize":102,"bidPrice":6.61,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-98.07143,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787169600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":6.51,"preHourTrading":{"tag":"盘前","latestPrice":6.56,"preClose":6.51,"latestTime":"08:14 EDT","volume":37,"amount":240.8645055,"timestamp":1787141696573,"change":0.05,"changeRate":0.00768,"amplitude":0.041475},"postHourTrading":{"tag":"盘后","latestPrice":6.5,"preClose":6.51,"latestTime":"19:55 EDT","volume":536,"amount":3659.49,"timestamp":1787097331648,"change":-0.01,"changeRate":-0.001536,"amplitude":0.001536},"volumeRatio":0.057163},"requestUrl":"/m/hq/s/SPRC/tweets","defaultTab":"tweets","newsList":[{"id":"1171251007","title":"Scisparc子公司Neurothera Labs完成540万加元融资，Scisparc持股估值约3000万加元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171251007","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171251007?lang=zh_cn&edition=full","pubTime":"2026-08-18 20:07","pubTimestamp":1787054829,"startTime":"0","endTime":"0","summary":"Scisparc宣布，其旗下子公司Neurothera Labs已成功完成一轮总额为540万加元的融资。此次融资完成后，Scisparc所持有的Neurothera Labs股权估值已达到约3000万加元。这一进展标志着Neurothera Labs在资本运作上迈出了关键一步，同时也进一步巩固了Scisparc在该公司中的战略地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113820930","title":"SciSparc旗下Neurothera Labs获日本专利，独家创新疗法组合受保护","url":"https://stock-news.laohu8.com/highlight/detail?id=1113820930","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113820930?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:26","pubTimestamp":1786537611,"startTime":"0","endTime":"0","summary":"SciSparc Ltd.子公司Neurothera Labs近日迎来重大利好——其自主研发的一款创新疗法组合，已成功获得日本专利局授予的专利权。这项专利的获批，意味着该公司的独家治疗技术在日本市场得到了知识产权层面的强力保障，为其后续的商业化布局与国际化拓展，奠定了坚实的法律基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105287951","title":"Scisparc旗下Neurothera Labs在耶鲁儿童研究中心启动首创性图雷特综合征疗法IIb期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1105287951","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105287951?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:23","pubTimestamp":1785932612,"startTime":"0","endTime":"0","summary":"SciSparc Ltd.旗下子公司Neurothera Labs，于耶鲁大学儿童研究中心正式启动一项IIb期临床试验——该试验针对的是一种首创性图雷特综合征治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146555978","title":"Scisparc宣布进军代理式AI市场，并组建人工智能与网络安全科学顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1146555978","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146555978?lang=zh_cn&edition=full","pubTime":"2026-07-27 20:26","pubTimestamp":1785155195,"startTime":"0","endTime":"0","summary":"SciSparc Ltd.正式宣布，其战略决策已明确指向代理式人工智能市场。这家公司决心在这一新兴领域发力，同步组建了专注于人工智能与网络安全领域的科学顾问委员会。此举标志着该公司业务版图的重大拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139736204","title":"SciSparc 子公司 Neurothera Labs 宣布在德国汉诺威医学院启动治疗抽动秽语综合征的创新型疗法 IIb 期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1139736204","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139736204?lang=zh_cn&edition=full","pubTime":"2026-07-15 20:43","pubTimestamp":1784119425,"startTime":"0","endTime":"0","summary":"SciSparc Ltd.旗下子公司 Neurothera Labs 宣布，已启动一项针对抽动秽语综合征创新疗法的 IIb 期临床试验。该试验将在德国汉诺威医学院进行。此次临床研究的启动标志着该公司针对这一神经系统疾病的核心候选疗法进入了新的关键阶段。抽动秽语综合征是一种复杂的神经发育障碍，患者常出现不自主的抽动和发声。Neurothera Labs 的研发项目旨在探索新的治疗途径。汉诺威医学院作为欧洲领先的医学研究中心之一，将为此次临床试验提供专业的科研环境和临床资源。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110541230","title":"Scisparc子公司Neurothera Labs获附条件监管批准，将收购Cliniquantum","url":"https://stock-news.laohu8.com/highlight/detail?id=1110541230","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110541230?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:40","pubTimestamp":1779972024,"startTime":"0","endTime":"0","summary":"SciSparc Ltd.宣布，其子公司Neurothera Labs已获得附条件的监管批准，得以推进对Cliniquantum的收购事宜。此项批准标志着该交易在满足特定规定条件后，即将进入下一关键阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108138371","title":"SciSparc与Neurothera Labs及Clearmind Medicine合作 推动抑郁症疗法专利申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1108138371","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108138371?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:35","pubTimestamp":1773664511,"startTime":"0","endTime":"0","summary":"SciSparc Ltd.宣布，其与Neurothera Labs及Clearmind Medicine的合作已取得重要进展，三方共同提交了一项针对抑郁症治疗方法的专利申请。这一合作旨在结合各方在神经科学和药物研发领域的专长，开发创新的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101461005","title":"SciSparc Ltd.合作企业Neurothera Labs宣布与Clearmind Medicine联合申请的国际专利公布，靶向减肥与脂肪肝新疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1101461005","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101461005?lang=zh_cn&edition=full","pubTime":"2026-03-12 19:57","pubTimestamp":1773316636,"startTime":"0","endTime":"0","summary":"SciSparc Ltd.的合作方Neurothera Labs宣布，其与Clearmind Medicine共同开发的一项针对减重及脂肪肝疾病的新型疗法国际专利已正式公布。该专利标志着双方在代谢疾病治疗领域的合作取得重要进展，为开发创新疗法奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176827418","title":"SciSparc子公司Neurothera Labs签署最终协议，收购量子临床试验先驱Cliniquantum多数股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1176827418","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176827418?lang=zh_cn&edition=full","pubTime":"2026-03-10 21:28","pubTimestamp":1773149305,"startTime":"0","endTime":"0","summary":"SciSparc Ltd. (SPRC) 宣布，其持股75%的子公司Neurothera Labs已正式签署最终协议，将收购Cliniquantum的多数股权。Cliniquantum是一家专注于量子计算技术应用于临床实验领域的创新公司。此次收购标志着SciSparc在推进创新疗法和临床开发平台方面迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRC","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512854194","title":"Scisparc Ltd.盘中异动 快速跳水6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512854194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512854194?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:02","pubTimestamp":1739977362,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时02分，Scisparc Ltd.股票出现异动，股价大幅跳水6.79%。截至发稿，该股报0.460美元/股，成交量8.6211万股，换手率0.80%，振幅3.87%。Scisparc Ltd.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为362.50%、223.90%、82.90%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Allogene Therapeutics, Inc.，振幅分别为207.68%、119.61%、36.97%。Scisparc Ltd.公司简介：SciSparc Ltd 是一家专业临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230243a24c028f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230243a24c028f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRC","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512166011","title":"Scisparc Ltd.盘中异动跌6.68% 振幅达7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512166011?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:06","pubTimestamp":1739891194,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时06分，Scisparc Ltd.股票出现波动，股价大幅下挫6.68%。截至发稿，该股报0.465美元/股，成交量199.271万股，换手率18.40%，振幅7.98%。Scisparc Ltd.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Solid Biosciences Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为338.80%、129.09%、120.41%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029、Allogene Therapeutics, Inc.，振幅分别为148.75%、41.79%、35.54%。Scisparc Ltd.公司简介：SciSparc Ltd 是一家专业临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021823063596279e6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021823063596279e6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRC","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511069609","title":"Scisparc Ltd.盘中异动 大幅下挫5.16%报0.502美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511069609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511069609?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:44","pubTimestamp":1739544265,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时44分，Scisparc Ltd.股票出现异动，股价大幅跳水5.16%。截至发稿，该股报0.502美元/股，成交量2.0343万股，换手率0.19%，振幅4.73%。Scisparc Ltd.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1626.02%、450.49%、409.59%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。Scisparc Ltd.公司简介：SciSparc Ltd 是一家专业临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224425abcf098f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224425abcf098f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510806303","title":"Scisparc Ltd.盘中异动 股价大跌7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510806303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510806303?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284318,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Scisparc Ltd.股票出现波动，股价大幅跳水7.00%。截至发稿，该股报0.522美元/股，成交量13.5898万股，换手率1.26%，振幅0.93%。Scisparc Ltd.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Lipella Pharmaceuticals Inc.、In8Bio, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为1925.31%、517.35%、174.57%，振幅较大的相关个股有In8Bio, Inc.、Akari Therapeutics Plc、Ocean Biomedical, Inc.，振幅分别为25.06%、16.07%、15.54%。Scisparc Ltd.公司简介：SciSparc Ltd 是一家专业临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223158abcb0615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223158abcb0615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRC","BK4007","BK4139","OCEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510189850","title":"Scisparc Ltd.盘中异动 大幅拉升5.81%报0.525美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510189850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510189850?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:15","pubTimestamp":1739207752,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时15分，Scisparc Ltd.股票出现异动，股价快速上涨5.81%。截至发稿，该股报0.525美元/股，成交量35.4905万股，换手率3.28%，振幅9.03%。Scisparc Ltd.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Dominari Holdings Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2941.96%、1594.16%、1162.59%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.，振幅分别为99.86%、87.80%、85.48%。Scisparc Ltd.公司简介：SciSparc Ltd 是一家专业临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211011553abc9c88d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211011553abc9c88d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509744722","title":"Scisparc Ltd.盘中异动 快速跳水5.16%报0.415美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509744722?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:46","pubTimestamp":1738939582,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时46分，Scisparc Ltd.股票出现异动，股价大幅跳水5.16%。截至发稿，该股报0.415美元/股，成交量4.6454万股，换手率0.43%，振幅2.28%。Scisparc Ltd.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2424.89%、59.75%、48.06%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Omega Therapeutics, Inc.，振幅分别为130.43%、58.71%、27.94%。Scisparc Ltd.公司简介：SciSparc Ltd 是一家专业临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224622987db056&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224622987db056&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509282428","title":"Scisparc Ltd.盘中异动 急速上涨6.60%报0.429美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509282428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509282428?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:37","pubTimestamp":1738766225,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时37分，Scisparc Ltd.股票出现波动，股价急速上涨6.60%。截至发稿，该股报0.429美元/股，成交量9401股，换手率0.09%，振幅4.22%。Scisparc Ltd.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3051.81%、783.21%、632.89%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为54.05%、34.67%、23.35%。Scisparc Ltd.公司简介：SciSparc Ltd 是一家专业临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223705abc37f27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223705abc37f27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","BK4007","BK4139","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508572954","title":"Scisparc Ltd.盘中异动 快速拉升5.63%报0.467美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508572954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508572954?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:30","pubTimestamp":1738679443,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时30分，Scisparc Ltd.股票出现波动，股价快速上涨5.63%。截至发稿，该股报0.467美元/股，成交量16.9045万股，换手率1.56%，振幅0.00%。Scisparc Ltd.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Azitra Inc、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon、Invivyd, Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为823.55%、667.60%、183.21%，振幅较大的相关个股有Azitra Inc、Omega Therapeutics, Inc.、Kairos Pharma, Ltd.，振幅分别为13.82%、5.64%、5.26%。Scisparc Ltd.公司简介：SciSparc Ltd 是一家专业临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042230439617d75b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042230439617d75b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","SPRC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508418431","title":"Scisparc Ltd.盘中异动 早盘股价大跌6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508418431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508418431?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:33","pubTimestamp":1738593191,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时33分，Scisparc Ltd.股票出现波动，股价大幅跳水6.00%。截至发稿，该股报0.423美元/股，成交量5.4387万股，换手率0.50%，振幅0.00%。Scisparc Ltd.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为339.46%、264.17%、128.76%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Briacell Therapeutics Corp.，振幅分别为57.05%、33.33%、20.32%。Scisparc Ltd.公司简介：SciSparc Ltd 是一家专业临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223311a23809d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223311a23809d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SPRC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508967201","title":"Scisparc Ltd.盘中异动 股价大涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508967201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508967201?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:41","pubTimestamp":1738341680,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日00时41分，Scisparc Ltd.股票出现波动，股价急速拉升6.43%。截至发稿，该股报0.470美元/股，成交量18.5153万股，换手率1.71%，振幅8.67%。Scisparc Ltd.股票所在的生物技术行业中，整体涨幅为1.37%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃，换手率分别为2109.65%、1934.51%、179.37%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为71.20%、56.30%、52.24%。Scisparc Ltd.公司简介：SciSparc Ltd 是一家专业临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502010041209614faa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502010041209614faa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507222936","title":"Scisparc Ltd.盘中异动 早盘大幅下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507222936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507222936?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:14","pubTimestamp":1738250054,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时14分，Scisparc Ltd.股票出现波动，股价大幅跳水5.14%。截至发稿，该股报0.455美元/股，成交量14.1661万股，换手率1.31%，振幅10.08%。Scisparc Ltd.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为1348.84%、176.33%、175.88%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited、Kazia Therapeutics Limited，振幅分别为56.41%、52.92%、42.03%。Scisparc Ltd.公司简介：SciSparc Ltd 是一家专业临床阶段制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302314149876b6bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302314149876b6bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRC","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scisparc.com","stockEarnings":[{"period":"1week","weight":-0.0455},{"period":"1month","weight":0.302},{"period":"3month","weight":0.5878},{"period":"6month","weight":0.2825},{"period":"1year","weight":-0.8407},{"period":"ytd","weight":-0.4681}],"compareEarnings":[{"period":"1week","weight":-0.004},{"period":"1month","weight":0.0325},{"period":"3month","weight":0.0353},{"period":"6month","weight":0.1212},{"period":"1year","weight":0.193},{"period":"ytd","weight":0.1254}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"SciSparc Ltd.是一家制药公司，于2004年8月23日在以色列注册成立并开始运营。公司是一家临床专业的制药公司。该公司的重点是创建和加强基于大麻素疗法的技术和资产组合。基于此，公司目前正致力于以下基于Δ9-四氢大麻酚（THC）和非精神活性大麻酚（CBD）的开发项目：THX-110用于治疗抽动秽语综合征（TS）和阻塞性睡眠呼吸暂停症；THX-160用于治疗慢性和急性疼痛；THX-210用于治疗慢性和急性疼痛自闭症谱系障碍和癫痫的治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.075328},{"month":2,"riseRate":0.2,"avgChangeRate":-0.14034},{"month":3,"riseRate":0,"avgChangeRate":-0.320237},{"month":4,"riseRate":0.4,"avgChangeRate":0.283936},{"month":5,"riseRate":0.6,"avgChangeRate":-0.008039},{"month":6,"riseRate":0,"avgChangeRate":-0.212405},{"month":7,"riseRate":0.2,"avgChangeRate":-0.13712},{"month":8,"riseRate":0,"avgChangeRate":-0.391089},{"month":9,"riseRate":0.25,"avgChangeRate":0.236982},{"month":10,"riseRate":0.75,"avgChangeRate":0.077569},{"month":11,"riseRate":0.5,"avgChangeRate":0.007929},{"month":12,"riseRate":0.25,"avgChangeRate":-0.09099}],"exchange":"NASDAQ","name":"SciSparc Ltd.","nameEN":"SciSparc Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SciSparc Ltd.(SPRC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SciSparc Ltd.(SPRC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SciSparc Ltd.,SPRC,SciSparc Ltd.股票,SciSparc Ltd.股票老虎,SciSparc Ltd.股票老虎国际,SciSparc Ltd.行情,SciSparc Ltd.股票行情,SciSparc Ltd.股价,SciSparc Ltd.股市,SciSparc Ltd.股票价格,SciSparc Ltd.股票交易,SciSparc Ltd.股票购买,SciSparc Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SciSparc Ltd.(SPRC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SciSparc Ltd.(SPRC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}